Health care startups that raised Series B in Tokyo, Japan
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| BionicM | Tokyo | Series B | $4.5M | 2026-11-02 |
| Celaid Therapeutics | Tokyo | Series B | $2.5M | 2026-10-05 |
| Restore Vision | Tokyo | Series B | $8.2M | 2026-04-15 |
| Adacotech | Tokyo | Series B | $8.6M | 2022-04-27 |
4 rows of the CSV in 5 of its 18 columns.
- The 21 health care startups in Tokyo, Japan whose last round is Series B have raised $261.0M in total.
- 5 of them closed their most recent round in the last 12 months, $48.0M combined.
- The largest of those rounds is Neusignal Therapeutics' $32.8M Series B, dated June 2026.
- The most recent is BionicM's $4.5M Series B on 2 November 2026.
- UTEC - The University of Tokyo Edge Capital Partners is an investor in 4 of them, more than any other fund.
- Biotech is the most common other sector, with 10 companies (48%).
- 29% were founded in 2020 or later; the median founding year is 2017.
- The most common team size is 11 to 50 employees (65% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
3 of 21| Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|
| BionicM | BionicM develops high-performance robotic prostheses that improve mobility for people with disabilities. | Hardware | Series B | $4.5M | 2026-11-02 | $15.5M | UTEC - The University of Tokyo Edge Capital Partners, UTokyo Innovation Platform, Shinsei Corporate Investment +1 | 11 to 50 | 2018 |
| Celaid Therapeutics | Celaid Therapeutics develops cell therapies for blood cancer, intractable blood diseases, and genetic disorders. | Biotech | Series B | $2.5M | 2026-10-05 | $17.1M | UTEC - The University of Tokyo Edge Capital Partners, Osaka University Venture Capital, Joyo Capital Partners | 1 to 10 | 2020 |
| Restore Vision | Restore Vision develops a gene therapy to restore vision for patients with retinitis pigmentosa. | Biotech | Series B | $8.2M | 2026-04-15 | $26.7M | SMBC Venture Capital, ANRI, Spiral Capital +2 | 1 to 10 | 2016 |
Table 1. Health care startups that raised Series B in Tokyo, Japan: the 3 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 21.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Restore Vision | Restore Vision develops a gene therapy to restore vision for patients with retinitis pigmentosa. | Biotech | Series B | $8.2M | 2026-04-15 | $26.7M | SMBC Venture Capital, ANRI, Spiral Capital +2 | 1 to 10 | 2016 |
| 2 | BionicM | BionicM develops high-performance robotic prostheses that improve mobility for people with disabilities. | Hardware | Series B | $4.5M | 2026-11-02 | $15.5M | UTEC - The University of Tokyo Edge Capital Partners, UTokyo Innovation Platform, Shinsei Corporate Investment +1 | 11 to 50 | 2018 |
| 3 | Celaid Therapeutics | Celaid Therapeutics develops cell therapies for blood cancer, intractable blood diseases, and genetic disorders. | Biotech | Series B | $2.5M | 2026-10-05 | $17.1M | UTEC - The University of Tokyo Edge Capital Partners, Osaka University Venture Capital, Joyo Capital Partners | 1 to 10 | 2020 |
Table 2. Health care startups that raised Series B in Tokyo, Japan: the 3 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | UTEC - The University of Tokyo Edge Capital Partners | Venture capital firm | Tokyo, Japan | 4 | 19% | 2 | BionicM, Celaid Therapeutics |
| 2 | UTokyo Innovation Platform | Startup accelerator | Tokyo, Japan | 2 | 10% | 1 | BionicM |
| 3 | Spiral Capital | Venture capital firm | Tokyo, Japan | 2 | 10% | 1 | Restore Vision |
| 4 | Shinsei Corporate Investment | Venture capital firm | Otemachi, Japan | 1 | 5% | 1 | BionicM |
| 5 | Chibagin Capital | Venture capital firm | Chiba, Japan | 1 | 5% | 1 | BionicM |
| 6 | Joyo Capital Partners | Venture capital firm | 1 | 5% | 1 | Celaid Therapeutics | |
| 7 | Osaka University Venture Capital | Venture capital firm | Osaka, Japan | 1 | 5% | 1 | Celaid Therapeutics |
| 8 | Kyoto University Innovation Capital | University program | Kyoto, Japan | 1 | 5% | 1 | Restore Vision |
| 9 | ANRI | Venture capital firm | Tokyo, Japan | 1 | 5% | 1 | Restore Vision |
| 10 | SMBC Venture Capital | Corporate venture arm | Tokyo, Japan | 1 | 5% | 1 | Restore Vision |
| 11 | JIC Venture Growth Investments | Venture capital firm | Marunouchi, Japan | 1 | 5% | 1 | Restore Vision |
| 12 | DNX Ventures | Venture capital firm | San Mateo, United States | 1 | 5% | ||
| 13 | FinTech Global | Investment bank | Tokyo, Japan | 1 | 5% | ||
| 14 | Tohoku University Venture Partners | Venture capital firm | Sendai-shi, Japan | 1 | 5% | ||
| 15 | Glocalink | Venture capital firm | Singapore | 1 | 5% |
Table 3. Health care startups that raised Series B in Tokyo, Japan: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Biotech | 10 | 48% | $179.0M |
| Software | 5 | 24% | $13.9M |
| Hardware | 3 | 14% | $15.5M |
| Artificial intelligence | 3 | 14% | $13.9M |
| Commerce | 1 | 5% | |
| Energy | 1 | 5% |
Table 4. Health care startups that raised Series B in Tokyo, Japan by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series B | 21 | 100% | $10.0M |
Table 5. Health care startups that raised Series B in Tokyo, Japan by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| November 2026 | 1 | 20% | $4.5M |
| October 2026 | 1 | 20% | $2.5M |
| June 2026 | 1 | 20% | $32.8M |
| April 2026 | 1 | 20% | $8.2M |
| January 2026 | 1 | 20% |
Table 6. Health care startups that raised Series B in Tokyo, Japan: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 5 | 24% | $48.0M |
| 2025 | 3 | 14% | $27.6M |
| 2024 | 3 | 14% | $44.5M |
| 2022 | 4 | 19% | $60.7M |
| 2021 | 2 | 10% | $442K |
| 2020 | 1 | 5% | $6.6M |
Table 7. Health care startups that raised Series B in Tokyo, Japan by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2020 to 2022 | 6 | 29% |
| 2015 to 2019 | 10 | 48% |
| 2010 to 2014 | 3 | 14% |
| Before 2010 | 2 | 10% |
Table 8. Health care startups that raised Series B in Tokyo, Japan by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 5 | 25% |
| 11 to 50 | 13 | 65% |
| 51 to 100 | 1 | 5% |
| 501 to 1,000 | 1 | 5% |
Table 9. Health care startups that raised Series B in Tokyo, Japan by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Health care is one of its sectors and its most recent funding round is Series B and its headquarters is in Tokyo, Japan. On 16 November 2026 that is 21 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 3 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 21 rows: 3 have no round amount, 0 no city and 6 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many health care startups in Tokyo, Japan whose last round is Series B are on the list?
- 21, in the file dated 16 November 2026. 5 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 21 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.